title: Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
abstract: With the emergence of very virulent Marek's disease virus (MDV) strains, vaccines based on herpesvirus of turkeys (HVT) appear to be not powerful enough to confer full protection, whereas in chicken flocks vaccinated with MDV CVI 988 strain protective immunity sometimes is generated not early enough for full protection. For this reason combination vaccines containing HVT as well as CVI 988 have been developed. In this paper the beneficial effect of combining both types of virus strains in one vaccine for early protection is shown in a vaccination challenge experiment, in which one-day-old chickens were vaccinated with suboptimal dosages of the monovalent vaccines and the same dosages in a combination vaccine. After 5 days the chickens were challenged with a very virulent MDV strain and subsequently observed for a period of approx. 50 days. It appeared that the combination vaccine provided better early protection than the monovalent vaccines. In addition, the combination vaccine was tested as vaccine administered in ovo. It appeared that after in ovo vaccination the vaccine conferred adequate protection against challenge with a very virulent MDV strain, 5 days after hatch, and that protection after in ovo vaccination was similar to that obtained after subcutaneous vaccination with the same combination vaccine.
authors.affiliation: Fort Dodge Animal Health Holland, Bio R&D Department, Weesp, The Netherlands. geerlih@md.ahp.com
authors.forename: H J
authors.initials: HJ
authors.lastname: Geerligs
authors.forename: M W
authors.initials: MW
authors.lastname: Weststrate
authors.forename: T L
authors.initials: TL
authors.lastname: Pertile
authors.forename: J
authors.initials: J
authors.lastname: Rodenberg
authors.forename: M
authors.initials: M
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Chu
mesh_terms: D000818:Animals; D002645:Chickens; D018142:Gammaherpesvirinae / Q000276:immunology*; D008381:Herpesvirus 2, Gallid / Q000276:immunology* / Q000472:pathogenicity*; D008380:Marek Disease / Q000517:prevention & control* / Q000821:virology; D014422:Turkeys / Q000821:virology; D014611:Vaccination / Q000662:veterinary; D017778:Vaccines, Combined / Q000008:administration & dosage / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*; D014774:Virulence
chemical_list: D017778:Vaccines, Combined; D014765:Viral Vaccines